Haematopoietic stem cell transplants should be a second-line therapy for highly active MS - Commentary

Research output: Contribution to journalShort survey

Original languageEnglish (US)
Pages (from-to)1263-1265
Number of pages3
JournalMultiple Sclerosis
Volume22
Issue number10
DOIs
StatePublished - Sep 1 2016

Fingerprint

Hematopoietic Stem Cells
Transplants
Therapeutics

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Haematopoietic stem cell transplants should be a second-line therapy for highly active MS - Commentary. / Mowry, Ellen Mahar.

In: Multiple Sclerosis, Vol. 22, No. 10, 01.09.2016, p. 1263-1265.

Research output: Contribution to journalShort survey

@article{59dfae0808ca4cc283da1e03f651e669,
title = "Haematopoietic stem cell transplants should be a second-line therapy for highly active MS - Commentary",
author = "Mowry, {Ellen Mahar}",
year = "2016",
month = "9",
day = "1",
doi = "10.1177/1352458516660206",
language = "English (US)",
volume = "22",
pages = "1263--1265",
journal = "Multiple Sclerosis",
issn = "1352-4585",
publisher = "SAGE Publications Ltd",
number = "10",

}

TY - JOUR

T1 - Haematopoietic stem cell transplants should be a second-line therapy for highly active MS - Commentary

AU - Mowry, Ellen Mahar

PY - 2016/9/1

Y1 - 2016/9/1

UR - http://www.scopus.com/inward/record.url?scp=84986567882&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84986567882&partnerID=8YFLogxK

U2 - 10.1177/1352458516660206

DO - 10.1177/1352458516660206

M3 - Short survey

C2 - 27444561

AN - SCOPUS:84986567882

VL - 22

SP - 1263

EP - 1265

JO - Multiple Sclerosis

JF - Multiple Sclerosis

SN - 1352-4585

IS - 10

ER -